MONTREAL and CHARLOTTE, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of ...
WASHINGTON, June 1, 2026 /PRNewswire/ -- In recognition of SVT Awareness Day, the Heart Rhythm Society (HRS) and Milestone Pharmaceuticals are partnering to expand supraventricular tachycardia (SVT) ...
DENVER — Heart disease in young people is certainly possible. Supraventricular tachycardia (SVT) can affect kids, adolescents and young adults. It occurs in about 2 out of every 1,000 people. SVT ...
Supraventricular tachycardia (SOO-prah-ven-TRIK-u-lar tak-eh-KAR-dee-ah), or SVT, is a condition that causes your heart to beat faster than it should. Bouts of SVT are often short. You might feel ...
Photo Credit: AHA/Scott Morgan 2022. Used with permission. CHICAGO, IL—Full results of the RAPID trial testing etripamil nasal spray for patients with paroxysmal supraventricular tachycardia (PSVT) ...
The US Food and Drug Administration has approved etripamil nasal spray (Cardamyst) for adults with acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT), drugmaker Milestone ...
Self-treatment of acute paroxysmal supraventricular tachycardia (SVT) with a nasal spray containing a short-acting calcium-channel blocker is likely to be possible with a high rate of conversion to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results